Literature DB >> 25871961

Subclinical hypercortisolism in adrenal incidentaloma.

Miguel Debono1, John Newell-Price.   

Abstract

PURPOSE OF REVIEW: The article aims to update the reader on current developments in the area of adrenal incidentaloma complicated by subclinical hypercortisolism. We will discuss different diagnostic strategies and complications associated with this disease, and address the conflicting opinions related to the treatment of these patients. RECENT
FINDINGS: Depending on diagnostic criteria used, between 30 and 50% of patients with adrenocortical incidentaloma have biochemical hypercortisolism, but lack classical external features of Cushing's syndrome. The challenge facing the clinician is that in the sixth and seventh decade of life hypertension, diabetes, osteoporosis and obesity are common and establishing whether these are directly related to the low-grade excess cortisol secretion in a given individual is not straightforward. Nevertheless, this subclinical hypercortisolism has been found to be associated with multiple cardiovascular risk factors, an increased predisposition to cardiovascular events and a higher mortality rate. The dilemma is that it is not established whether surgical excision of the adrenal adenoma in a given individual will improve these complications, and data demonstrate that surgical studies are conflicting.
SUMMARY: Subclinical hypercortisolism is associated with multiple complications and definite guidelines for diagnosis are necessary. Prospective, randomized controlled studies are needed to ascertain whether medical or surgical interventions are justified, and in which patients.

Entities:  

Mesh:

Year:  2015        PMID: 25871961     DOI: 10.1097/MED.0000000000000151

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  13 in total

1.  Interference in ACTH immunoassay negatively impacts the management of subclinical hypercortisolism.

Authors:  Serkan Yener; Leyla Demir; Mustafa Demirpence; Mustafa Mahmut Baris; Ilgin Yildirim Simsir; Secil Ozisik; Abdurrahman Comlekci; Tevfik Demir
Journal:  Endocrine       Date:  2017-02-28       Impact factor: 3.633

Review 2.  Autonomous cortisol secretion in adrenal incidentalomas.

Authors:  Marta Araujo-Castro; Miguel Antonio Sampedro Núñez; Mónica Marazuela
Journal:  Endocrine       Date:  2019-03-07       Impact factor: 3.633

3.  Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center.

Authors:  Luigi Petramala; Giuseppe Cavallaro; Matteo Galassi; Cristiano Marinelli; Gianfranco Tonnarini; Antonio Concistrè; Umberto Costi; Maurizio Bufi; Piernatale Lucia; Giuseppe De Vincentis; Gino Iannucci; Giorgio De Toma; Claudio Letizia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-01-31

4.  Evaluation of body composition using dual-energy X-ray absorptiometry in patients with non-functioning adrenal incidentalomas and an intermediate phenotype: Is there an association with metabolic syndrome?

Authors:  A B Moraes; E M R Cavalari; M P de Paula; M Arruda; D S C Curi; R A Leitão; L M C de Mendonça; M L F Farias; M Madeira; L Vieira Neto
Journal:  J Endocrinol Invest       Date:  2018-11-21       Impact factor: 4.256

5.  Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed.

Authors:  M P de Paula; A B Moraes; M das Graças Coelho de Souza; E M R Cavalari; R C Campbell; G da Silva Fernandes; M L F Farias; L M C Mendonça; M Madeira; E Bouskela; L G Kraemer-Aguiar; L Vieira Neto
Journal:  J Endocrinol Invest       Date:  2020-07-19       Impact factor: 4.256

6.  Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.

Authors:  M Vieira-Correa; R B Giorgi; K C Oliveira; L F Hayashi; F A Costa-Barbosa; C E Kater
Journal:  J Endocrinol Invest       Date:  2019-08-27       Impact factor: 4.256

7.  ADRENAL ADENOMA WITH AUTONOMOUS CORTISOL SECRETION ACCOMPANIED BY HOMOLATERAL RENAL CELL CARCINOMA: A CASE REPORT.

Authors:  C Liu; H Zhang; X Li
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jan-Mar       Impact factor: 0.877

Review 8.  Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing's Syndrome.

Authors:  Lynnette K Nieman
Journal:  Endocr Rev       Date:  2022-09-26       Impact factor: 25.261

9.  Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.

Authors:  Jekaterina Patrova; Magnus Kjellman; Hans Wahrenberg; Henrik Falhammar
Journal:  Endocrine       Date:  2017-09-08       Impact factor: 3.633

10.  Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH).

Authors:  Pejman Cohan; Honey E East; Sandi-Jo Galati; Jennifer U Mercado; Precious J Lim; Michele Lamerson; James J Smith; Anne L Peters; Kevin C J Yuen
Journal:  J Clin Endocrinol Metab       Date:  2019-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.